반려동물 진단 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Companion Animal Diagnostic Market size is expected to reach USD 16.04 Billion in 2034 from USD 7.07 Billion (2025) growing at a CAGR of 9.52% during 2026-2034.

The companion animal diagnostic market has expanded significantly as pet ownership and pet humanization trends rise worldwide. Veterinary clinics increasingly utilize advanced diagnostic tools such as hematology analyzers, immunoassays, molecular diagnostics, and imaging systems to detect diseases early and improve treatment outcomes. Growth in preventive care awareness has also boosted routine screening demand.

Key drivers include higher spending on pet healthcare, advancements in point-of-care testing, and the availability of rapid diagnostic kits. Technological innovation in portable analyzers and tele-veterinary services enhances accessibility and efficiency. Increasing incidence of zoonotic and chronic diseases in pets further fuels diagnostic demand.

Future prospects are strong as pet insurance penetration increases and emerging markets witness rising adoption of companion animals. Development of AI-assisted diagnostic platforms and genomic testing may reshape veterinary care. Despite cost sensitivity in some regions, the market is expected to sustain healthy growth supported by ongoing innovation and emotional attachment between owners and pets.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Animal

• Dogs
• Cats
• Horses
• Other Companion Animals

By Technology

• Clinical Biochemistry
• Immunodiagnostics
• Hematology
• Molecular Diagnostics
• Urinalysis
• Others

By Application

• Clinical Pathology
• Bacteriology
• Virology
• Parasitology
• Others

By End Use

• Diagnostic Laboratories
• Veterinary Hospitals And Clinics
• Point-Of-Care/In-House Testing
• Research Institutes And Universities

COMPANIES PROFILED

• Zoetis, Biomrieux, Heska Corporation, Idexx Laboratories Inc, Idvet, Neogen Corporation, Qiagen, Randox Laboratories Ltd, Thermo Fisher Scientific Inc, Virbac

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL COMPANION ANIMAL DIAGNOSTIC MARKET: BY ANIMAL 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Animal
• 4.2. Dogs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Cats Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Horses Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Other Companion Animals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL COMPANION ANIMAL DIAGNOSTIC MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Clinical Biochemistry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Immunodiagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Hematology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Molecular Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Urinalysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL COMPANION ANIMAL DIAGNOSTIC MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Clinical Pathology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Bacteriology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Virology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Parasitology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL COMPANION ANIMAL DIAGNOSTIC MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Veterinary Hospitals And Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Point-Of-Care/In-House Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Research Institutes And Universities Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL COMPANION ANIMAL DIAGNOSTIC MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Animal
  • 8.2.2 By Technology
  • 8.2.3 By Application
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Animal
  • 8.3.2 By Technology
  • 8.3.3 By Application
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Animal
  • 8.4.2 By Technology
  • 8.4.3 By Application
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Animal
  • 8.5.2 By Technology
  • 8.5.3 By Application
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Animal
  • 8.6.2 By Technology
  • 8.6.3 By Application
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL COMPANION ANIMAL DIAGNOSTIC INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Zoetis
  • 10.2.2 BiomAfA(C)Rieux
  • 10.2.3 Heska Corporation
  • 10.2.4 Idexx Laboratories Inc
  • 10.2.5 Idvet
  • 10.2.6 Neogen Corporation
  • 10.2.7 Qiagen
  • 10.2.8 Randox Laboratories Ltd
  • 10.2.9 Thermo Fisher Scientific Inc
  • 10.2.10 Virbac